Salarius Pharmaceuticals Inc (SLRX)
2.45
-0.03
(-1.21%)
USD |
NASDAQ |
Jun 27, 16:00
2.40
-0.05
(-2.04%)
After-Hours: 20:00
Salarius Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.0039 |
December 31, 2020 | 0.0215 |
September 30, 2020 | 0.0369 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.014 |
December 31, 2019 | 0.0475 |
September 30, 2019 | 0.0769 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.0769
Maximum
Sep 2019
0.0182
Average
0.0039
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Masimo Corp | 0.6417 |
Esperion Therapeutics Inc | -0.8904 |
SINTX Technologies Inc | 0.0235 |
Flora Growth Corp | 0.9809 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.884M |
Total Liabilities (Quarterly) | 1.234M |
Shareholders Equity (Quarterly) | 3.650M |